Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DIO Corporation (039840.KQ)
KRW12,600.00
+400.00 (+3.28%)
KR KOE Healthcare Medical - Instruments & Supplies
Address
66, Centum seo-ro 612-020
Busan, KR
Busan, KR
CEO
Jin-Baek Kim
Website
dio.co.kr
IPO
2000-09-14
ISIN KR7039840004
Description
Based in South Korea, DIO Corporation is a key player in the manufacturing and distribution of dental implants. Its extensive range of implant systems includes UFII internal (both submerged and non-submerged), FTN external, and protem mini systems. The company further provides UV active components, activators, and essential instrument kits. In addition to dental implants, DIO offers dental digital solutions, a variety of dental products, and cardiovascular medical devices. Its global reach extends to approximately 70 countries through its export activities. The firm, which was founded in 1988, was initially known as DSI Co., Ltd before rebranding as DIO Corporation in August 2008. It is headquartered in Busan, South Korea.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW12,600.00
+400.00 (+3.28%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
38.0K
Beta
0.49
Float Shares
8.77M
Free Float %
67.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.21% | -3.66% | -13.13% | -15.03% | -9.06% | -7.66% | -18.80% | -48.08% | -58.09% | -67.74% | +310.29% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
12,600.00
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.83
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%+37.1% ★ Q1'26: +15.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%+96.7% ★ Q1'26: +7,397.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+1.2% Q1'26: -0.6% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+6.2% Q1'26: +5.2% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+4.5% Q1'26: +3.1% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%-0.3% ★ Q1'26: +15.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×4.14× Q1'26: 4.50× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 4 Rev. Ana. 4 EPS Ana. |
Dec 2028 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
71.94B
est: 72.50B (-0.8%)
|
88.02B
est: 90.10B (-2.3%)
|
91.92B
est: 95.00B (-3.2%)
|
91.04B
est: 90.90B (+0.2%)
|
127.17B
est: 126.82B (+0.3%)
|
120.06B
est: 119.86B (+0.2%)
|
150.04B
est: 150.00B (+0.0%)
|
131.31B
est: 131.00B (+0.2%)
|
155.82B
est: 156.00B (-0.1%)
|
119.65B
est: 119.65B (0.0%)
|
164.08B
est: 163.08B (+0.6%)
|
196.28B
189.86B – 212.36B
+20.4% YoY
|
235.30B
219.90B – 256.01B
+19.9% YoY
|
281.00B
266.73B – 304.96B
+19.4% YoY
|
| EBITDA |
22.60B
est: 6.83B (+231.0%)
|
29.11B
est: 8.48B (+243.1%)
|
18.71B
est: 8.95B (+109.2%)
|
13.98B
est: 8.56B (+63.4%)
|
41.36B
est: 11.94B (+246.4%)
|
29.52B
est: 11.29B (+161.5%)
|
49.69B
est: 14.13B (+251.7%)
|
-2.91B
est: 12.34B (-123.6%)
|
30.44B
est: 14.69B (+107.2%)
|
-33.43B
est: 8.24B (-505.8%)
|
19.57B
est: 11.23B (+74.3%)
|
13.51B
13.07B – 14.62B
+20.4% YoY
|
16.20B
15.14B – 17.62B
+19.9% YoY
|
19.34B
18.36B – 20.99B
+19.4% YoY
|
| EBIT |
20.38B
est: 609.75M (+3,242.3%)
|
26.23B
est: 757.77M (+3,361.0%)
|
14.67B
est: 798.98M (+1,736.4%)
|
8.14B
est: 764.49M (+964.8%)
|
32.52B
est: 1.07B (+2,949.4%)
|
19.98B
est: 1.01B (+1,881.8%)
|
38.27B
est: 1.26B (+2,933.5%)
|
-16.08B
est: 1.10B (-1,559.5%)
|
18.13B
est: 1.31B (+1,281.8%)
|
-44.67B
est: -1.49B (-2,898.6%)
|
10.19B
est: -2.03B (+601.9%)
|
-2.44B
-2.64B – -2.36B
-20.4% YoY
|
-2.93B
-3.19B – -2.74B
-19.9% YoY
|
-3.50B
-3.80B – -3.32B
-19.4% YoY
|
| Net Income |
9.25B
est: 10.05B (-8.0%)
|
20.51B
est: 18.68B (+9.8%)
|
8.56B
est: 18.05B (-52.6%)
|
5.45B
est: 11.74B (-53.5%)
|
21.73B
est: 21.76B (-0.1%)
|
11.15B
est: 11.31B (-1.4%)
|
28.25B
est: 26.62B (+6.1%)
|
-20.46B
est: -18.27B (-12.0%)
|
3.31B
est: 3.36B (-1.5%)
|
-41.32B
est: -41.64B (+0.8%)
|
-1.36B
est: 815.78M (-267.1%)
|
22.25B
18.78B – 24.46B
+2,626.9% YoY
|
29.52B
25.63B – 37.38B
+32.7% YoY
|
34.00B
31.75B – 37.77B
+15.2% YoY
|
| SGA |
5.77B
est: 9.56B (-39.6%)
|
8.99B
est: 11.88B (-24.3%)
|
12.65B
est: 12.52B (+1.1%)
|
13.68B
est: 11.98B (+14.2%)
|
15.30B
est: 16.71B (-8.4%)
|
10.00B
est: 15.80B (-36.7%)
|
16.10B
est: 19.77B (-18.6%)
|
22.49B
est: 17.27B (+30.3%)
|
21.29B
est: 20.56B (+3.5%)
|
19.21B
est: 17.73B (+8.3%)
|
27.13B
est: 24.17B (+12.2%)
|
29.09B
28.14B – 31.47B
+20.4% YoY
|
34.88B
32.59B – 37.95B
+19.9% YoY
|
41.65B
39.53B – 45.20B
+19.4% YoY
|
| EPS |
751.00
est: 697.00 (+7.7%)
|
1,409.52
est: 1,295.00 (+8.8%)
|
595.42
est: 1,251.50 (-52.4%)
|
379.08
est: 814.00 (-53.4%)
|
1,482.84
est: 1,508.83 (-1.7%)
|
758.93
est: 784.00 (-3.2%)
|
1,931.51
est: 1,845.75 (+4.6%)
|
-1,380.09
est: -1,267.00 (-8.9%)
|
227.00
est: 233.00 (-2.6%)
|
-2,865.10
est: -2,897.00 (+1.1%)
|
-94.85
est: 56.75 (-267.1%)
|
1,547.50
1,306.49 – 1,701.70
+2,626.9% YoY
|
2,053.67
1,783.26 – 2,600.63
+32.7% YoY
|
2,365.00
2,208.87 – 2,627.18
+15.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-18 | B | 3/5 | 1/5 | 3/5 | 4/5 | 2/5 | 2/5 | 4/5 |
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
52.84B
OE per share TTM
3,665.25
Owner's Yield
22.69%
Maintenance CapEx ratio
397.19%
Maint CapEx / Avg PPE
92.6%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 27 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 361.7K | 0.06% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 19.5K | 0.46% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 54.3K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 56.8K | 0.29% |
| 5 | Vanguard FTSE Developed Asia Pacific All Cap Index ETF VA.TO | 0.00% | 1.3K | 0.22% |
| 6 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 44.5K | 0.28% |
| 7 | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing V3AL.L | 0.00% | 6.3K | 0.24% |
| 8 | Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating V3AA.L | 0.00% | 6.3K | 0.24% |
| 9 | Vanguard FTSE Developed All Cap ex U.S. Index ETF (CAD-hedged) VEF.TO | 0.00% | 2.6K | 0.22% |
| 10 | Vanguard FTSE Developed All Cap ex U.S. Index ETF VDU.TO | 0.00% | 1.7K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
22.54M
Shares Outstanding
12.97M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dong-Gun Jung | Chief of Research and Development | — | — |
| Jin-Baek Kim | Chief Executive Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 039840.KQ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
